Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.
Vaccine. 2019 Jan 14;37(3):516-523. doi: 10.1016/j.vaccine.2018.11.052. Epub 2018 Dec 6.
Vaccine. 2019.
PMID: 30528328
Free article.